0001225208-21-002258.txt : 20210211 0001225208-21-002258.hdr.sgml : 20210211 20210211180438 ACCESSION NUMBER: 0001225208-21-002258 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210210 FILED AS OF DATE: 20210211 DATE AS OF CHANGE: 20210211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fitzgerald Joseph Michael CENTRAL INDEX KEY: 0001484186 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 21621405 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2021-02-10 0000885725 BOSTON SCIENTIFIC CORP BSX 0001484186 Fitzgerald Joseph Michael 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP & Pres, Interven Cardio Common Stock 2021-02-08 5 G 0 3040.0000 0.0000 D 231603.0000 D Common Stock 2021-02-10 4 A 0 17995.0000 0.0000 A 249598.0000 D Common Stock 2021-02-10 4 F 0 8881.0000 38.8500 D 240717.0000 D Common Stock 2021-02-08 5 G 0 1520.0000 0.0000 A 6038.0000 I By Children Common Stock 68312.0000 I By 401(k) This transaction involved a gift of securities by the reporting person to his children, two of whom share reporting person's household. Mr. Fitzgerald's holdings include 15 shares of common stock, which, due to an administrative error, had not been previously reported. On February 15, 2018, the reporting person was awarded a target number of performance share units under the Company's 2018 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person would be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2020 and subject to the completion of the concurrent three-year individual service period. On February 9, 2021, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied. The reporting person disclaims beneficial ownership of the shares held by his children, and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose. Shares held by one of his children, who is no longer considered a dependent, have been removed from this report. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. /s/ Scott G. Hodgdon, Attorney-in-Fact 2021-02-11